Resources

Anti-N-Methyl-D-Aspartate-Receptor Encephalitis: A 10-Year Follow-Up February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242611/

Learn more
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors February 27, 2021

https://journals.sagepub.com/doi/full/10.1177/1756286420932797

Learn more
Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146067/

Learn more
Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Contro February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381144/

Learn more
Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834766/

Learn more
Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406672/

Learn more
A Tale of Two Brothers: Familial Voltage-Gated Potassium Channel Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372199/

Learn more
Neurological Syndromes Associated with Anti-GAD Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279468/

Learn more
Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346383/

Learn more
Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118211/

Learn more